Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

BACKGROUND: Colon cancer is a top lethal cancer in man and women worldwide and drug resistance is the major cause of cancer-related death. Combinational therapy and drug delivery with nanoparticles have been shown to effectively overcome drug resistance in many cancers. We previously reported that n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yali, Zhang, Kunpeng, Zhu, Xingyao, Zheng, Xiuyan, Wang, Chao, Niu, Xiao, Jiang, Teng, Ji, Xinhua, Zhao, Weilin, Pang, Lijuan, Qi, Yan, Li, Feng, Li, Li, Xu, Zhiping, Gu, Wenyi, Zou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979685/
https://www.ncbi.nlm.nih.gov/pubmed/33758505
http://dx.doi.org/10.2147/IJN.S290731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979685/
https://www.ncbi.nlm.nih.gov/pubmed/33758505
http://dx.doi.org/10.2147/IJN.S290731

Ejemplares similares